Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Orthobiologics Market Today And What Is Its Future Size?

The orthobiologics market has experienced significant growth in past years, expanding from a size of $7.08 billion in 2024 to $7.48 billion in 2025, this signifies a compound annual growth rate (CAGR) of 5.7%. The growth during this historical period can be traced back to various factors including the increasing instances of orthopedic diseases and ailments, a transition towards less invasive procedures, a rise in reconstructive surgeries, increased spending on healthcare, better awareness amongst both patients and healthcare providers, and also economic advancements in emerging markets.

In the coming years, the orthobiologics market size is predicted to experience robust growth, expanding to $9.39 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 5.8%. Key elements driving growth during this projection period include an increasing elderly population and inactive ways of life, continuous evolution of superior products, beneficial reimbursement policies, as well as regulatory approvals for novel orthobiologic products and broader applications for existing orthobiologic products. Significant trends projected for this period comprise advancements in regenerative medicine, product innovation, technological progress, strategic initiatives and expansion of the market.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16139&type=smp

What External And Internal Drivers Are Influencing The Orthobiologics Market?

The surge in road mishaps and sports-related injuries is anticipated to fuel the expansion of the orthobiologics market. These incidents, which result in physical injury to individuals often involving their musculoskeletal system, are caused by various factors including distracted driving, over-speeding, poor road conditions, overexertion, the use of improper sports equipment, and lack of appropriate training. Orthobiologics are instrumental in treating these injuries by facilitating faster and better healing of musculoskeletal tissues, reducing inflammation, and boosting the body’s natural recuperative processes with the use of materials like bone grafts, stem cells, growth factors, and platelet-rich plasma. For example, Eurostat, the EU’s statistical agency, reported that in March 2024, fatalities due to road mishaps in Europe had risen by 3.7% from 19917 in 2021 to 20653 in 2022. Therefore, the rising incidence of sports injuries and road mishaps is expected to drive growth in the orthobiologics market.

How Is The Orthobiologics Market Categorized Across Applications And Types?

The orthobiologicsmarket covered in this report is segmented –

1) By Product Type: Viscosupplements; Bone Growth Factors; Demineralized Bone Matrix; Synthetic Bone Substitutes; Cellular Allograft; Other Products

2) By Application: Spinal Fusion; Maxillofacial And Dental; Soft Tissue Repair; Reconstructive And Fracture Surgery; Other Applications

3) By End User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End Users

Subsegments:

1) By Viscosupplements: Hyaluronic Acid Injections; Gel-Based Viscosupplements; Cross-linked Hyaluronic Acid; Other Viscosupplement Products

2) By Bone Growth Factors: Bone Morphogenetic Proteins (BMPs); Recombinant Human Bone Morphogenetic Proteins (rhBMPs); Platelet-Rich Plasma (PRP); Osteogenic Protein-1 (OP-1); Growth Factors For Bone Healing

3) By Demineralized Bone Matrix: DBM Grafts; DBM Putty; DBM Sponges; DBM Paste And Chips

4) By Synthetic Bone Substitutes: Calcium Phosphate-Based Substitutes; Calcium Sulfate-Based Substitutes; Tricalcium Phosphate (TCP); Hydroxyapatite (HA); Bioactive Glasses; Other Synthetic Bone Substitutes

5) By Cellular Allograft: Osteocellular Allografts; Mesenchymal Stem Cells (MSCs) Allografts; Bone Marrow-Derived Cellular Allografts; Adipose Tissue-Derived Cellular Allografts

6) By Other Products: Autografts; Collagen-Based Grafts; Synthetic Bone Graft Substitutes (Non-Bioactive); Amniotic Membrane-Based Grafts; Exosome-Based Products; Other Miscellaneous Orthobiologic Products

How Are Market Trends Influencing Competition In The Orthobiologics Market?

Top-tier companies in the orthobiologics market are pioneering state-of-the-art solutions like dry allograft mixtures to improve orthopedic procedure outcomes, specifically bone healing and fusion. These mixtures combine sturdy cortical fibers with mineralized cortical bone, thereby offering structural stability and fostering osteoinductive qualities that facilitate the formation of new bone. For example, Isto Biologics, an American biologics-centric firm, introduced in May 2024, the Fibrant Liberty allograft. This dry allograft blend incorporates resilient cortical fibers with mineralized cortical cancellous chips. Once hydrated, the graft acquires flexibility and can be tailored for a range of surgical procedures. The enhanced length and strength of the fibers optimize handling and create a complex network that inhibits graft displacement while upholding structural solidity.

Who Are The Global Leaders Steering The Orthobiologics Market Forward?

Major companies operating in the orthobiologics market are Johnson & Johnson, Medtronic plc, Zimmer Biomet, Arthrex Inc., Integra Lifesciences Corporation, NuVasive Inc., Globus Medical, Bioventus, MTF Biologics, ATEC Spine Inc., Exactech Inc., SeaSpine, RTI Surgical, AlloSource, XTANT MEDICAL, Spine Wave Inc., Bone Biologics Corp., Locate Bio Limited, Wright Medical Group N.V., BoneSupport AB, Graftys, Regenexx, Acumed LLC, Baxter International Inc., LifeNet Health

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report

What Are The Emerging Regional Trends Driving The Orthobiologics Market?

North America was the largest region in the orthobiologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthobiologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16139&type=smp

Browse Through More Reports Similar to the Global Orthobiologics Market 2025, By The Business Research Company

Oral Biologics And Biosimilars Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-global-market-report

Biologics Contract Development Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

Biologics Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model